OUR MISSION:
To partner with healthcare providers, payers, patients and advocacy groups to eradicate colorectal cancer.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Exact Sciences Announces Aetna Medicare Advantage to Cover Cologuard®

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ:EXAS) today announced that Aetna, one of the country's leading health plans, will cover Cologuard under its Medicare Advantage plan, reaching 967,000 members across the country. The three year agreement will go into effect on April 1, 2015. Cologuard is the first and only FDA approved noninvasive...Read more

Exact Sciences Awarded $9 Million in Tax Credits from WEDC

Agreement Offers Performance-Based Incentive to Create More than 750 Jobs, Invest $26 Million in Wisconsin  Madison, Wisc., February 23, 2015 – The Wisconsin Economic Development Corporation (WEDC) announced today that it will provide tax credits of up to $9 million to Exact Sciences Corp. (NASDAQ: EXAS) as part of the cancer diagnostics company’s ongoing growth in the state. The credits can...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More